TrimRx's Blog
Mounjaro Cancer Risk — What Evidence Shows | TrimrX
Mounjaro cancer risk concerns stem from rodent thyroid tumor data, but human trials show no increased cancer incidence. Here’s what patients need to know.
Mounjaro Black Box Warning — What Patients Need to Know
Mounjaro doesn’t have a black box warning, but it carries serious FDA safety alerts. Learn the thyroid cancer risk, contraindications, and what to watch
Mounjaro Thyroid Cancer — Risk, Evidence & What to Know
Mounjaro carries a black box warning for thyroid C-cell tumors based on animal studies. Here’s what the evidence shows and who should avoid it.
Mounjaro 5mg — Dosing, Effects & What to Expect | TrimRx
Mounjaro 5mg marks the first therapeutic dose in tirzepatide treatment. Learn precise dosing protocols, expected outcomes, and what distinguishes this
Mounjaro 10mg — Dosage, Results & What to Expect | TrimRx
Mounjaro 10mg delivers sustained weight loss through dual GIP/GLP-1 receptor action. Here’s the clinical data, titration schedule, and realistic
Mounjaro Highest Dose — 15mg Weekly Explained | TrimRx
The highest Mounjaro dose is 15mg weekly, approved for long-term metabolic management. Learn titration timelines, efficacy data, and safety monitoring
Wegovy Powerlifting — Muscle Preservation on GLP-1s
Wegovy reduces appetite but doesn’t inherently spare muscle — powerlifters need 1.2–1.6g protein per pound bodyweight and progressive overload to prevent
Wegovy for Cyclists — Performance, Safety & Dosing Explained
Wegovy (semaglutide) slows gastric emptying and reduces appetite — affecting endurance, hydration, and power-to-weight ratio for cyclists through GLP-1
Wegovy for Triathletes — Performance, Safety & Real Results
Wegovy triathletes face unique metabolic demands. Learn how GLP-1 therapy affects endurance performance, recovery, and race-day fueling strategies.